Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial (Q33411822)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial |
scientific article |
Statements
1 reference
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial (English)
1 reference
Charles A Dinarello
1 reference
Keith Stockerl-Goldstein
1 reference
Lawrence Chang
1 reference
Attaphol Pawarode
1 reference
John M Magenau
1 reference
Gregory A Yanik
1 reference
Oleg I Krijanovski
1 reference
Sung Won Choi
1 reference
Thomas Braun
1 reference
James L M Ferrara
1 reference
Guoqing Hou
1 reference
Steve Goldstein
1 reference
Daniel R Couriel
1 reference
Carrie Kitko
1 reference
Michael H Lehmann
1 reference
Isao Tawara
1 reference
Yaping Sun
1 reference
Markus Y Mapara
1 reference
John F DiPersio
1 reference
Pavan Reddy
1 reference
30 November 2013
1 reference
1 reference
15
1 reference
87-95
1 reference
Identifiers
1 reference
1 reference
1 reference